Home > Boards > US Listed > Biotechs > Adamis Pharmaceuticals Corporation (ADMP)

Indeed. Plenty of big news on the horizon

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BigT82 Member Profile
 
Followed By 10
Posts 2,606
Boards Moderated 2
Alias Born 12/24/14
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2021 10:32:44 AM
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders Business Wire - 6/14/2021 9:00:00 AM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 6/14/2021 6:03:38 AM
Adamis begins clinical trial start-up activities for COVID drug; shares rise 5% Seeking Alpha - 6/11/2021 8:33:04 AM
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 GlobeNewswire Inc. - 6/11/2021 7:30:00 AM
Adamis Pharma soars 18% after FDA accepts Zimhi application for review Seeking Alpha - 6/9/2021 7:46:12 AM
Adamis Provides Update on ZIMHI™ GlobeNewswire Inc. - 6/9/2021 7:30:00 AM
Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19 GlobeNewswire Inc. - 6/7/2021 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/2/2021 5:37:32 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 6/2/2021 8:20:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2021 4:37:06 PM
Adamis Pharmaceuticals Provides Business Update GlobeNewswire Inc. - 6/1/2021 7:30:00 AM
Adamis pharmaceuticals gets deficiency letter from NASDAQ Seeking Alpha - 5/28/2021 4:09:47 PM
Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ GlobeNewswire Inc. - 5/28/2021 4:04:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2021 5:12:17 PM
Amended Notification That Quarterly Report Will Be Submitted Late (nt 10-q/a) Edgar (US Regulatory) - 5/24/2021 5:22:16 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/17/2021 4:17:20 PM
Adamis Pharmaceuticals Provides Update on First Quarter 2021 Financial Results Conference Call GlobeNewswire Inc. - 5/17/2021 4:05:00 PM
Adamis resubmits ZIMHI opioid overdose treatment NDA Seeking Alpha - 5/17/2021 7:45:45 AM
Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA for the Treatment of Opioid Overdose GlobeNewswire Inc. - 5/17/2021 7:30:00 AM
Adamis Pharmaceuticals Schedules First Quarter 2021 Financial Results Conference Call and Business Update GlobeNewswire Inc. - 5/12/2021 7:30:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 4:51:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2021 5:04:55 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2021 5:04:18 PM
Adamis Pharmaceuticals misses on revenue Seeking Alpha - 4/15/2021 4:55:17 PM
BigT82   Wednesday, 05/05/21 04:11:05 PM
Re: Rollgard1 post# 2502
Post # of 2688 
Indeed. Plenty of big news on the horizon to get this one moving north just like our other favorite ticker. Really looking forward to ZIMHI news, in particular. Any day now on resubmission then approval.

Tic toc…

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences